Correlation Between BC Bud and Crescita Therapeutics
Can any of the company-specific risk be diversified away by investing in both BC Bud and Crescita Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BC Bud and Crescita Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between The BC Bud and Crescita Therapeutics, you can compare the effects of market volatilities on BC Bud and Crescita Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BC Bud with a short position of Crescita Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of BC Bud and Crescita Therapeutics.
Diversification Opportunities for BC Bud and Crescita Therapeutics
0.2 | Correlation Coefficient |
Modest diversification
The 3 months correlation between BCBCF and Crescita is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding The BC Bud and Crescita Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crescita Therapeutics and BC Bud is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on The BC Bud are associated (or correlated) with Crescita Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crescita Therapeutics has no effect on the direction of BC Bud i.e., BC Bud and Crescita Therapeutics go up and down completely randomly.
Pair Corralation between BC Bud and Crescita Therapeutics
If you would invest 0.30 in The BC Bud on August 29, 2024 and sell it today you would earn a total of 4.25 from holding The BC Bud or generate 1416.67% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
The BC Bud vs. Crescita Therapeutics
Performance |
Timeline |
BC Bud |
Crescita Therapeutics |
BC Bud and Crescita Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with BC Bud and Crescita Therapeutics
The main advantage of trading using opposite BC Bud and Crescita Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BC Bud position performs unexpectedly, Crescita Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crescita Therapeutics will offset losses from the drop in Crescita Therapeutics' long position.BC Bud vs. Amexdrug | BC Bud vs. Crescita Therapeutics | BC Bud vs. Antisense Therapeutics Limited | BC Bud vs. Aion Therapeutic |
Crescita Therapeutics vs. Rezolute | Crescita Therapeutics vs. Tempest Therapeutics | Crescita Therapeutics vs. Forte Biosciences | Crescita Therapeutics vs. Dyadic International |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |